US Broker Ratings

Surgery Partners, Inc. (SGRY) Investor Outlook: Analyzing an 88.83% Potential Upside

For investors eyeing the healthcare sector, Surgery Partners, Inc. (NASDAQ: SGRY) presents an intriguing opportunity, particularly given the notable potential upside of 88.83% suggested by current..

Kiniksa Pharmaceuticals Interna (KNSA) Stock Analysis: Unlocking a 24% Upside Potential

Kiniksa Pharmaceuticals International, plc (NASDAQ: KNSA) is capturing the attention of savvy investors with its impressive growth trajectory and robust product pipeline. As a biopharmaceutical company..

Sotera Health Company (SHC) Stock Analysis: Healthcare Sector’s Promising 17% Upside

Sotera Health Company (NASDAQ: SHC), a key player in the healthcare sector specializing in diagnostics and research, presents an intriguing opportunity for investors with a reported..

Ultragenyx Pharmaceutical Inc. (RARE): Investor Outlook Reveals a Promising 168% Potential Upside

As the healthcare sector continues to capture investor attention, Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) stands out with its focus on rare and ultra-rare genetic diseases. Despite..

Amneal Pharmaceuticals, Inc. (AMRX) Stock Analysis: Navigating Growth in the Generics Market

Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX), a prominent player in the healthcare sector, operates within the niche of drug manufacturers specializing in both specialty and generic pharmaceuticals...

Alvotech (ALVO) Investor Outlook: Exploring a 331% Potential Upside in the Biosimilars Market

Alvotech (NASDAQ: ALVO) stands out in the healthcare sector as a burgeoning force in the biosimilars market, poised for significant growth. With a market capitalization of..

Merus N.V. (MRUS) Stock Analysis: Evaluating a 7.78% Potential Upside in the Biotech Sector

Merus N.V. (MRUS), a biotechnology company at the forefront of immuno-oncology, presents an intriguing opportunity for investors keen on the healthcare sector. Headquartered in Utrecht, Netherlands,..

NewAmsterdam Pharma (NAMS) Stock Analysis: Exploring a 40% Upside Potential in Biotech Innovation

NewAmsterdam Pharma Company N.V. (NAMS) is making waves in the biotechnology sector with its innovative approach to treating metabolic diseases. As a late-stage biopharmaceutical company headquartered..

Concentra Group Holdings (CON): Analyzing a 23% Upside Potential in Healthcare

Concentra Group Holdings Parent, Inc. (CON) is positioning itself as a formidable player in the healthcare sector, specifically within the medical care facilities industry. Based in..

Apogee Therapeutics, Inc. (APGE) Stock Analysis: Exploring a 67.85% Potential Upside in the Biotechnology Sector

Apogee Therapeutics, Inc. (NASDAQ: APGE), a burgeoning player in the biotechnology industry, has captured the attention of investors with its promising pipeline of innovative therapies and..

ImmunityBio, Inc. (IBRX) Investor Outlook: Analyzing the 70% Upside Potential in Biotech Innovation

ImmunityBio, Inc. (NASDAQ: IBRX) is capturing the attention of investors with its innovative approach in the biotechnology sector, especially as it navigates through the healthcare landscape..

Arcellx, Inc. (ACLX) Investor Outlook: Analysts See 63% Upside Potential for Biotech Innovator

Arcellx, Inc. (NASDAQ: ACLX), a dynamic player in the biotechnology sector, is capturing the attention of investors with a compelling upside potential of 63.3%. Specializing in..

Scholar Rock Holding Corporation (SRRK) Stock Analysis: A Biotechnology Contender with a 5.24% Upside

Scholar Rock Holding Corporation (NASDAQ: SRRK) is turning heads in the biotechnology sector with its innovative approach to drug development. Headquartered in Cambridge, Massachusetts, this biopharmaceutical..

ICU Medical, Inc. (ICUI) Stock Analysis: Exploring a 19% Upside Potential in the Healthcare Sector

ICU Medical, Inc. (NASDAQ: ICUI), a prominent player in the healthcare sector specializing in medical instruments and supplies, represents a compelling opportunity for investors seeking growth..

Envista Holdings Corporation (NVST) Stock Analysis: Is Its Current Valuation Justified?

Envista Holdings Corporation (NYSE: NVST) stands as a formidable player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization..

Xenon Pharmaceuticals Inc. (XENE) Investor Outlook: Strong Buy Ratings and 31.57% Potential Upside

Xenon Pharmaceuticals Inc. (NASDAQ: XENE), a cutting-edge player in the biotechnology sector, is making waves with its neuroscience-focused approach to therapeutics. Headquartered in Burnaby, Canada, Xenon..

Zai Lab Limited (ZLAB) Stock Analysis: Exploring a 137.94% Potential Upside in the Biotech Sector

Zai Lab Limited (NASDAQ: ZLAB), a notable player in the biotechnology industry, is capturing the attention of investors with its promising potential upside of 137.94%. As..

PROCEPT BioRobotics Corporation (PRCT) Stock Analysis: Unpacking a 73.66% Potential Upside

For investors with an interest in innovative healthcare solutions, PROCEPT BioRobotics Corporation (NASDAQ: PRCT) offers a compelling narrative. Specializing in surgical robotics, PROCEPT is making significant..

Haemonetics Corporation (HAE) Stock Analysis: Exploring a 52.54% Potential Upside in the Medical Devices Sector

Haemonetics Corporation (NYSE: HAE), a prominent player in the healthcare sector, specifically within the medical devices industry, stands out with a market capitalization of $2.7 billion...

Metsera, Inc. (MTSR) Stock Analysis: Navigating the -19.15% Potential Downside in the Biotechnology Sector

Metsera, Inc. (MTSR) stands out in the biotechnology sector with its innovative approach to addressing obesity and related diseases through the development of hormone analog peptides...

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds